LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.06 | 27.76 | 689 | 360 | 1.9139 | 1.3839 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.06 | 27.76 | 724 | 360 | 2.0111 | 1.4161 | MN20160318_Q01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 8.76 | 27.76 | 747 | 401 | 1.8622 | 1.3502 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 8.76 | 27.76 | 3 | 401 | 0.0075 | -0.4387 | MN20160318_Q01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 8.76 | 27.76 | 786 | 401 | 1.9594 | 1.3815 | MN20160318_Q01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.46 | 27.76 | 806 | 438 | 1.8375 | 1.3302 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.46 | 27.76 | 855 | 438 | 1.9492 | 1.3649 | MN20160318_Q01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.17 | 27.76 | 3 | 489 | 0.0061 | -0.4158 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.17 | 27.76 | 853 | 489 | 1.7441 | 1.2877 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.17 | 27.76 | 4 | 489 | 0.0082 | -0.3738 | MN20160318_Q01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.17 | 27.76 | 904 | 489 | 1.8484 | 1.3200 | MN20160318_Q01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 13.87 | 27.76 | 2 | 604 | 0.0033 | -0.4466 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 13.87 | 27.76 | 912 | 604 | 1.5082 | 1.1937 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 13.87 | 27.76 | 14 | 604 | 0.0232 | -0.1427 | MN20160318_Q01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 13.87 | 27.76 | 985 | 604 | 1.6289 | 1.2320 | MN20160318_Q01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 15.58 | 27.76 | 2 | 685 | 0.0029 | -0.4337 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 15.58 | 27.76 | 954 | 685 | 1.3915 | 1.1481 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 15.58 | 27.76 | 30 | 685 | 0.0438 | 0.0169 | MN20160318_Q01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 15.58 | 27.76 | 1022 | 685 | 1.4907 | 1.1803 | MN20160318_Q01 | E11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 17.28 | 27.76 | 5 | 838 | 0.0060 | -0.2943 | MN20160318_Q01 | D14 |